The outcome of living donors who are homozygous for the APOL1 variant is unknown; however, it is tempting to speculate that much, if not all, of the excess risk of renal failure in African American donors may be attributable to APOL1 risk variant [56•]. This evidence concerns the gene APOL1 and acute kidney injury.